Title of Study: Comparative Evaluation of Dexmedetomidine And Clonidine As An Adjuvant To Ropivacaine For Epidural Anaesthesia In Lower Abdominal Surgeries
DOI:
https://doi.org/10.61841/f12yat06Keywords:
Alpha 2-adrenergic agonists, ropivacaine, clonidine, dexmedetomidine, epidural anaesthesia, sedation, haemodynamic, stabilityAbstract
Background: Owing to its sedative and analgesic properties, alpha 2 adrenergic agonists improve the quality and duration of regional anaesthesia when added as an adjuvant. Objectives: The study objective was to evaluate and compare Ropivacaine given epidurally when given in combination with dexmedetomidine as compared to clonidine in terms of efficacy with emphasis on their onset and duration of action, haemodynamic stability and sedation. Methods: The study will be conducted in prospective, randomized manner. It will include 80 patients with ASA physical status I,II who are to undergo a lower abdominal procedure under epidural anaesthesia. Patients will be grouped into 2 randomly of 25 people each. Group RC will be given 15ml of 0.75% Ropivacaine and injection Clonidine 2mcg/kg epidurally. Group RD will be given 15ml of 0.75% Ropivacaine and injection Dexmeditomidine 1.5mcg/kg epidurally. The parameters assessed will be the haemodynamic stability, motor and sensory block onset and duration and sedation. Results: We hypothesize that both the groups will not show any significant difference in surgical characteristics or demographically and group RD will show better sedation scores and significantly shorter time of onset of blockade of motor and sensory innervation and also longer duration of analgesia as compared to group RC. Conclusion: We anticipate concluding that dexmedetomidine will be a superior neuraxial adjuvant to Ropivacaine for faster onset of analgesia, sedation and stable haemodynamic parameters as compared to clonidine.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
